HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mario Gonzalez-Gronow Selected Research

Voltage-Dependent Anion Channels

9/2014Binding of tissue-type plasminogen activator to the glucose-regulated protein 78 (GRP78) modulates plasminogen activation and promotes human neuroblastoma cell proliferation in vitro.
10/2010Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism.
9/2009GRP78: a multifunctional receptor on the cell surface.
11/2007Plasminogen structural domains exhibit different functions when associated with cell surface GRP78 or the voltage-dependent anion channel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mario Gonzalez-Gronow Research Topics

Disease

13Neoplasms (Cancer)
05/2022 - 02/2005
9Prostatic Neoplasms (Prostate Cancer)
12/2017 - 06/2002
4Melanoma (Melanoma, Malignant)
05/2022 - 01/2010
3Rheumatoid Arthritis
05/2022 - 11/2002
3Neuroblastoma
09/2014 - 10/2010
2Autoimmune Diseases (Autoimmune Disease)
05/2022 - 11/2002
2Multiple Sclerosis
05/2022 - 10/2015
2Teratocarcinoma
01/2021 - 09/2009
1Colorectal Neoplasms (Colorectal Cancer)
05/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2022
1Neuromyelitis Optica (Devic's Disease)
05/2022
1Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)
05/2022
1Central Nervous System Lupus Vasculitis
05/2022
1Nervous System Diseases (Neurological Disorders)
01/2021
1Type I Plasminogen Deficiency
01/2016
1Autism Spectrum Disorder
10/2015
1Ovarian Neoplasms (Ovarian Cancer)
02/2011
1Autistic Disorder (Autism)
10/2010
1Venous Thromboembolism
09/2010
1Cutaneous Malignant Melanoma
01/2010
1Dengue (Dengue Fever)
09/2009
1Neoplasm Metastasis (Metastasis)
02/2005
1Myocardial Infarction
11/2002
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2002
1Streptococcal Infections (Streptococcal Infection)
11/2002

Drug/Important Bio-Agent (IBA)

12Endoplasmic Reticulum Chaperone BiPIBA
05/2022 - 11/2005
11AutoantibodiesIBA
05/2022 - 11/2002
10Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2006
8Glucose (Dextrose)FDA LinkGeneric
05/2022 - 12/2006
6PlasminogenIBA
01/2016 - 06/2002
4Immunoglobulin G (IgG)IBA
01/2016 - 11/2002
4Voltage-Dependent Anion ChannelsIBA
09/2014 - 11/2007
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 10/2005
3EpitopesIBA
12/2017 - 12/2006
3Thromboplastin (Tissue Factor)IBA
12/2017 - 06/2002
3AntibodiesIBA
01/2016 - 12/2006
3Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2005 - 11/2002
2LigandsIBA
01/2021 - 10/2010
2Immunoglobulin A (IgA)IBA
01/2016 - 11/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
09/2014 - 01/2013
2Carrier Proteins (Binding Protein)IBA
09/2014 - 11/2002
2Immunoglobulins (Immunoglobulin)IBA
08/2011 - 02/2011
2Biomarkers (Surrogate Marker)IBA
02/2011 - 12/2006
2Protein Isoforms (Isoforms)IBA
01/2008 - 07/2005
2Adenosine DeaminaseIBA
01/2008 - 05/2004
2AngiostatinsIBA
10/2005 - 02/2005
1Myelin-Oligodendrocyte GlycoproteinIBA
05/2022
1Cell Surface ReceptorsIBA
01/2021
1AutoantigensIBA
01/2021
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
01/2021
1Prostate-Specific Antigen (Semenogelase)IBA
12/2017
1Pharmaceutical PreparationsIBA
12/2017
1Heparin (Liquaemin)FDA LinkGeneric
12/2017
1Molecular Chaperones (Chaperone, Molecular)IBA
12/2017
1AntigensIBA
01/2016
1IgA receptor (protein B)IBA
08/2011
1OligosaccharidesIBA
08/2011
1Protein Kinases (Protein Kinase)IBA
08/2011
1Immune Sera (Antisera)IBA
02/2011
1Immunodominant EpitopesIBA
02/2011
1HexokinaseIBA
10/2010
1plasminogen kringle 5IBA
09/2009
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
09/2009
1Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2007
1Adalimumab (Humira)FDA Link
11/2005
1EnzymesIBA
11/2005
1Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA
11/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2005
1AntiportersIBA
07/2005
1A-factor (Streptomyces)IBA
05/2004
1StreptokinaseFDA Link
11/2002

Therapy/Procedure

1Therapeutics
11/2005
1Thrombolytic Therapy
11/2002